Newshot - Day/Night Follow system Light Dark
Million-yuan CAR-T cancer drug included in China's basic medical insurance for first time, patient out-of-pocket cost drops to under 100,000 yuan
IT之家, November 14: According to 科创板日报, at the 2026 Innovative Drugs High-Quality Development Conference held today, the latest version of the National Medical Insurance Drug Catalog and the Commercial Insurance Innovative Drug Catalog were announced simultaneously.
IT之家 has learned that in the new version of the basic medical insurance catalog, 2 innovative drugs have been transferred from the previous first edition of the commercial insurance innovative drug catalog into basic medical insurance, reflecting further deepening of the coordination and linkage between the "medical insurance + commercial insurance" dual catalogs.
Among them, million-yuan-level CAR-T cancer therapy has achieved a historic breakthrough: 药明巨诺瑞基奥仑赛注射液（商品名：倍诺达 ®）has been included in basic medical insurance for the first time. After medical insurance reimbursement, patients' out-of-pocket expenses will drop to within 100,000 yuan. The core reason this "sky-high-priced drug" could enter basic medical insurance with a substantial price cut is that key raw materials have achieved domestic production, which can greatly reduce production costs.
In addition, last month the National Healthcare Security Administration upgraded the medical insurance wallet to version 2.0, supporting cross-provincial mutual assistance services through multiple channels including the 国家医保服务平台 App, 支付宝 mini program, and offline handling windows. Insured people can not only conveniently complete online operations such as binding and unbinding mutual assistance relationships, quota setting and use, and service inquiries without leaving home, but can also handle services at offline windows, making it convenient for older people and other special groups.
Related articles
- Breakthrough in gastric cancer treatment: China approves world's first CAR-T therapy for solid tumor treatment
- 114 new drugs enter 2025 National Medical Insurance Drug Catalog, 19 drugs included in first edition of Commercial Insurance Innovative Drug Catalog
- Online rumor about million-yuan "anti-cancer injection" is actually "CAR-T therapy"; experts say it is not a panacea
- Chinese medical team breaks through bottleneck in blood tumor treatment, world's first in vivo preparation of CAR-T therapy achieves clinical success
- First dosing for systemic lupus erythematosus: 莱芒生物's metabolism-enhanced CD19 CAR-T expands into autoimmune disease field
- Nature website headline: Chinese scholars publish world's first universal CAR-T treatment result
Websites under 软媒: IT之家 最会买 - rebate and cashback coupons iPhone之家 Win7之家 Win10之家 Win11之家
Software under 软媒: 软媒手机APP应用 魔方 最会买 要知